DNMT3A and acute myeloid leukemia: Although the results of DNMT3A mutations did not show statistical significance (Table 5, p = 0.059), it still indicated an adverse effect on the survival of AML patients (Table 5, HR: 1.371, 95% CI: 0.987–1.904).